Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

PURPOSE: Improvement of cure rates for patients treated with allogeneic hematopoietic stem-cell transplantation (HSCT) will require efforts to decrease treatment-related mortality from severe viral infections. Adoptively transferred virus-specific T cells (VSTs) generated from eligible, third-party...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Tzannou, Ifigeneia, Papadopoulou, Anastasia, Naik, Swati, Leung, Kathryn, Martinez, Caridad A., Ramos, Carlos A., Carrum, George, Sasa, Ghadir, Lulla, Premal, Watanabe, Ayumi, Kuvalekar, Manik, Gee, Adrian P., Wu, Meng-Fen, Liu, Hao, Grilley, Bambi J., Krance, Robert A., Gottschalk, Stephen, Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E., Leen, Ann M., Omer, Bilal
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2017
Pynciau:
ORIGINAL REPORTS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5662844/
https://ncbi.nlm.nih.gov/pubmed/28783452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.73.0655
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg